Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Galera Therapeutics, Inc. (GRTX) had Stock-Based Compensation of $0.23M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.07M |
|
-- |
|
-- |
|
$1.14M |
|
$-1.14M |
|
$0.06M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.14M |
|
$-1.14M |
|
98.50M |
|
98.50M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$5.95M |
|
-- |
|
$0.10M |
|
$6.05M |
|
$0.35M |
|
-- |
|
$151.05M |
|
$151.40M |
|
$-147.94M |
|
$-145.35M |
|
$-145.35M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-3.69M |
|
-- |
|
$0.64M |
|
$8.29M |
|
$5.23M |
|
$-3.06M |
|
|
Stock-Based Compensation |
$0.23M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.73% |
|
0.74% |
|
-17.77% |
|
0.74% |
|
$-1.93 |
|
$-0.04 |
|
$-0.04 |
|